Do not forget the trade receivables of $2,584,000 which I suspect are sales invoiced but not paid.
Printable View
Do not forget the trade receivables of $2,584,000 which I suspect are sales invoiced but not paid.
Actual sales of $1.9m, I thought the consensus was for $3.2m? (or was this for overall revenue including grants etc?)... commentary/presentation looks good and they continue to reiterate a 100m target is achievable
12m cash quote from ODT was therefore number 2 interpretation in my earlier post (12m was set aside for marketing)
Research Grant income a significant portion of the income line, BUT, a nice lift in receivables meaning some of those agreements are gaining traction. And Medicare WONT be included IMO (they didn't last year, so wouldn't change that without a note to accounts)
I see the only change in accounting policy is to accrue the Research Grant, rather than count when cash received, however, they state the difference is immaterial
Average result IMO but progress. I'll buy into a CR is there is one.
The buy orders are flowing in...
Ive got no link on anz --could someone kindly put it up?
go to NZX skid - there are 4 items
Does anyone know if there is a conference call we can join? If yes, can you please provide the details. Thanks :)
Seems to be a few people that don't have patience (as in a few people jumping on the bandwagon to sell)
MAC will be happy with this. Will validate his DCF valuation.
Where is MAC?